Pfiz­er and No­var­tis chiefs lead phar­ma's CEO in­flu­encers on so­cial me­dia, analy­sis finds

When it comes to phar­ma CEOs as so­cial in­flu­encers, Pfiz­er’s Al­bert Bourla is a per­fect 10 com­pared to his peers.

No­var­tis CEO Vas Narasimhan is a close sec­ond, though, with a 9.2 so­cial im­pact rat­ing — and his sta­tus is on the rise, ac­cord­ing to Cre­ation Health­care’s new analy­sis of phar­ma CEO so­cial in­flu­ence.

The Cre­ation Health­care analy­sis com­pared phar­ma lead­ers against each oth­er based on the num­ber of fol­low­ers, fre­quen­cy of posts, num­ber of likes re­ceived, and the num­ber of com­ments, both by the CEO and from read­ers, across so­cial me­dia chan­nels. LinkedIn was by far the most pop­u­lar plat­form for phar­ma CEOs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER